Anticholinesterase Agents has 18 known drug interactions based on U.S. FDA drug labeling data. 18 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine, Iodixanol, Povidine Iodine, Depo-Medrol, Lidocaine, Isopropyl Alcohol, Dexamethasone. Patients taking Anticholinesterase Agents should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 18
- Major
- 18
Major (18)
- Anticholinesterase Agents + Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine, Iodixanol, Povidine Iodine— Concomitant use may produce severe weakness in patients with myasthenia gravis.
- Anticholinesterase Agents + Depo-Medrol, Lidocaine, Isopropyl Alcohol— Concomitant use may produce severe weakness in patients with myasthenia gravis.
- Anticholinesterase Agents + Dexamethasone— Concomitant use may produce severe weakness in patients with myasthenia gravis.
- Anticholinesterase Agents + Dexamethasone 1.5 Mg— Concomitant use with dexamethasone may produce severe weakness in patients with myasthenia gravis.
- Anticholinesterase Agents + Dexamethasone Intensol— Concomitant use may produce severe weakness in patients with myasthenia gravis.
- Anticholinesterase Agents + Hydrocortisone Acetate— Concomitant use may produce severe weakness in patients with myasthenia gravis.
- Anticholinesterase Agents + Hydrocortisone Sodium Succinate— Concomitant use may produce severe weakness in patients with myasthenia gravis. Anticholinesterase agents should be with…
- Anticholinesterase Agents + Kenalog— Concomitant use with corticosteroids may produce severe weakness in patients with myasthenia gravis.
- Anticholinesterase Agents + Marcaine, Kenalog, Povidone Iodine— Concomitant use with corticosteroids may produce severe weakness in patients with myasthenia gravis.
- Anticholinesterase Agents + Marcaine, Lidocaine, Kenalog, Povidone Iodine— Concomitant use with corticosteroids may produce severe weakness in patients with myasthenia gravis.
- Anticholinesterase Agents + Methylprednisolone— Concomitant use may produce severe weakness in patients with myasthenia gravis. Anticholinesterase agents should be with…
- Anticholinesterase Agents + Methylprednisolone Acetate— Concomitant use may produce severe weakness in patients with myasthenia gravis. Withdraw anticholinesterases 24 hours be…
- Anticholinesterase Agents + Methylprednisolone Acetate, Lidocaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol— Concomitant use with corticosteroids may produce severe weakness in patients with myasthenia gravis.
- Anticholinesterase Agents + Methylprednisolone Sodium Succinate— Concomitant use with corticosteroids may produce severe weakness in patients with myasthenia gravis.
- Anticholinesterase Agents + Prednisolone Sodium Phosphate— Concurrent use may produce severe weakness in patients with myasthenia gravis; anticholinesterase agents should be withd…
- Anticholinesterase Agents + Prednisone— May produce severe weakness in patients with myasthenia gravis. Should be withdrawn at least 24 hours before initiating …
- Anticholinesterase Agents + Triamcinolone Acetonide— Concomitant use may produce severe weakness in patients with myasthenia gravis.
- Anticholinesterase Agents + Triamcinolone Acetonide Extended-Release Injectable Suspension— Concomitant use with corticosteroids may produce severe weakness in patients with myasthenia gravis.